Page last updated: 2024-10-24

regulation of interleukin-8 production

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate, or extent of interleukin-8 production. [GOC:mah]

Interleukin-8 (IL-8), also known as CXCL8, is a potent chemokine primarily produced by immune cells like macrophages, neutrophils, and epithelial cells. Its production is tightly regulated, responding to various stimuli and involving complex signaling pathways.

The regulation of IL-8 production is crucial for coordinating inflammatory responses, leukocyte recruitment, and wound healing. Its dysregulation contributes to various inflammatory diseases like rheumatoid arthritis and chronic obstructive pulmonary disease.

**Key Regulators of IL-8 Production:**

1. **Transcriptional Regulation:**
- **NF-κB:** Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is a master regulator of IL-8 transcription. Various stimuli, including bacterial lipopolysaccharide (LPS), TNF-α, and IL-1β, activate NF-κB signaling. This involves the phosphorylation and degradation of IκBα, an inhibitor of NF-κB, allowing the NF-κB dimer to translocate to the nucleus and bind to the IL-8 promoter, promoting gene expression.
- **AP-1:** Activator protein-1 (AP-1), a heterodimer composed of c-Fos and c-Jun, is another critical transcription factor involved in IL-8 expression. Activation of AP-1 pathways, often by mitogen-activated protein kinases (MAPKs), can induce IL-8 transcription.
- **STATs:** Signal transducer and activator of transcription (STAT) proteins play a role in IL-8 production, particularly in response to interferon (IFN) stimulation. IFN-γ can activate STAT1, which can bind to the IL-8 promoter, contributing to IL-8 expression.

2. **Post-Transcriptional Regulation:**
- **mRNA Stability:** The stability of IL-8 mRNA influences its abundance and the subsequent production of IL-8 protein. Factors like microRNAs (miRNAs) can target IL-8 mRNA for degradation, thus regulating its stability.
- **Translation:** Translation of IL-8 mRNA into protein can be regulated by various factors, including cellular stress and the availability of ribosomes.

3. **Other Factors:**
- **Cytokines:** Pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6 can induce IL-8 production by activating NF-κB and other signaling pathways.
- **Bacterial products:** LPS, a component of bacterial cell walls, is a potent inducer of IL-8 production, activating TLR4 and downstream signaling pathways.
- **Viral infections:** Viral infection can trigger IL-8 production by activating pattern recognition receptors (PRRs) and inducing the release of inflammatory mediators.
- **Reactive oxygen species (ROS):** Oxidative stress can lead to increased IL-8 production, contributing to inflammation.

**Regulation of IL-8 Production in Different Cell Types:**

- **Macrophages:** Macrophages are key producers of IL-8, responding to pathogens and inflammatory stimuli.
- **Neutrophils:** While not the primary producers, neutrophils also express IL-8, further amplifying inflammatory responses.
- **Epithelial cells:** Epithelial cells lining various tissues, including the lungs, gut, and skin, can produce IL-8 in response to infection and injury.

**Clinical Significance:**

- **Inflammatory Diseases:** Dysregulation of IL-8 production is implicated in various inflammatory diseases, including rheumatoid arthritis, Crohn's disease, and sepsis.
- **Cancer:** IL-8 can promote tumor growth and metastasis by enhancing angiogenesis and immune suppression.
- **Wound Healing:** IL-8 plays a crucial role in attracting neutrophils and other immune cells to the site of injury, contributing to wound healing.

**Therapeutic Targets:**

- **Inhibition of IL-8 production:** Targeting key signaling pathways like NF-κB and AP-1 can suppress IL-8 production, potentially reducing inflammation.
- **Neutralization of IL-8:** Anti-IL-8 antibodies or other neutralizing agents can block the biological activity of IL-8, mitigating its pro-inflammatory effects.

**Conclusion:**

Regulation of IL-8 production is a complex process involving multiple signaling pathways and cellular interactions. Understanding this intricate regulation is crucial for developing therapeutic strategies for inflammatory diseases and other disorders associated with dysregulated IL-8 expression.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Receptor-type tyrosine-protein phosphatase CA receptor-type tyrosine-protein phosphatase C that is encoded in the genome of human. [PRO:CNA, UniProtKB:P08575]Homo sapiens (human)

Compounds (10)

CompoundDefinitionClassesRoles
4-hydroxyphenylglyoxylic acid4-hydroxyphenylglyoxylate : Conjugate base of 4-hydroxyphenylglyoxylic acid.

4-hydroxyphenylglyoxylic acid: RN given refers to parent cpd
phenols
5-iodo-2-(oxaloamino)benzoic acidorganoiodine compound
9,10-phenanthrenequinone9,10-phenanthrenequinone: structurephenanthrenes
oleanolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
plant metabolite
1,2-naphthoquinone1,2-naphthoquinone : The parent structure of the family of 1,2-naphthoquinones, in which the oxo groups of the quinone moiety are at positions 1 and 2 of the naphthalene ring. It is a metabolite of naphthalene and is found in diesel exhaust particles.

naphthalene-1,2-dione: structure given in first source
1,2-naphthoquinonesaryl hydrocarbon receptor agonist;
carcinogenic agent
cryptotanshinonecryptotanshinone: from Salvia miltiorrhizaabietane diterpenoidanticoronaviral agent
2-(oxaloamino)benzoic acid(oxaloamino)benzoic acid
illudalic acidilludalic acid: isolated from Clitocybe illudens; structure in first source
3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1h-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1h-indole-5-carboxylic acid3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1H-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1H-indole-5-carboxylic acid: an SHP2 inhibitor; structure in first source
variabilinvariabilin: an RGD-containing antagonist of glycoprotein IIb-IIIa from the hard tick, Dermacentor variabilis; amino acid sequence given in first source